Wolverine Asset Management LLC Buys Shares of 176,000 Henry Schein, Inc. (NASDAQ:HSIC)

Wolverine Asset Management LLC bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, Holdings Channel.com reports. The fund bought 176,000 shares of the company’s stock, valued at approximately $12,179,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. FMR LLC grew its stake in shares of Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after acquiring an additional 237,888 shares during the last quarter. Southpoint Capital Advisors LP grew its stake in shares of Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after acquiring an additional 600,000 shares during the last quarter. Nuance Investments LLC grew its stake in shares of Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after acquiring an additional 414,748 shares during the last quarter. Clarkston Capital Partners LLC grew its stake in shares of Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after acquiring an additional 71,560 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Henry Schein by 0.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock worth $85,662,000 after acquiring an additional 6,184 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on HSIC. Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Barrington Research boosted their price target on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Thursday, January 30th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. Finally, Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Eight equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Henry Schein currently has an average rating of “Moderate Buy” and a consensus price target of $80.09.

Henry Schein Trading Up 0.3 %

Shares of NASDAQ:HSIC opened at $78.05 on Friday. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The company has a market capitalization of $9.73 billion, a PE ratio of 32.12, a PEG ratio of 2.19 and a beta of 0.91. The business has a 50 day moving average of $74.13 and a two-hundred day moving average of $72.15. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.